Xin Lang Cai Jing·2025-09-07 09:06Financial Performance - The company reported a significant decline in revenue, with operating income for the first half of the year at 10,942.90 million RMB, down 38.91% from 17,912.91 million RMB in the same period last year [1] - The total profit for the period was -4,279.89 million RMB, indicating a loss compared to the previous year's profit of -2,899.63 million RMB [1] - The net profit attributable to shareholders was -4,088.17 million RMB, worsening from -2,950.62 million RMB year-on-year [1] - The net profit after deducting non-recurring gains and losses was -4,589.61 million RMB, compared to -3,702.69 million RMB in the previous year [1] - The net cash flow from operating activities was -3,188.19 million RMB, an increase in loss from -2,495.72 million RMB in the same period last year [1] Historical Financial Data - From 2021 to 2024, the company achieved operating revenues of 486 million RMB, 261 million RMB, 322 million RMB, and 300 million RMB respectively [1] - The net profit attributable to shareholders for the same years was -129 million RMB, -288 million RMB, -208 million RMB, and -103 million RMB respectively [1] IPO and Stock Performance - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 20, 2020, with an initial offering price of 50.81 RMB per share and issued 19.33 million shares [1] - The stock is currently in a state of decline, having broken its initial offering price [1] - The total amount raised from the initial public offering was 982 million RMB, with a net amount of 864 million RMB, exceeding the originally planned fundraising amount by 364 million RMB [1] - The total issuance costs for the IPO were 118 million RMB (excluding VAT), with underwriting and sponsorship fees amounting to 96.34 million RMB [1]